Analyst Research: Agios Pharmaceuticals Inc (AGIO.OQ)

AGIO.OQ on NASDAQ Stock Exchange Global Select Market

120.78USD
22 Dec 2014
Price Change (% chg)

$1.16 (+0.97%)
Prev Close
$119.62
Open
$118.75
Day's High
$122.79
Day's Low
$116.93
Volume
222,184
Avg. Vol
249,204
52-wk High
$124.09
52-wk Low
$21.40

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - AGIOS PHARMACEUTICALS INC (AGIO-O) 5 Dec 2014 Thomson Reuters Stock Report 11 25.00
ValuEngine Rating and Forecast Report for AGIO 30 Nov 2014 ValuEngine, Inc. 11 25.00
Agios Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 28 Nov 2014 Reuters Investment Profile 12 20.00
Value Graph: AGIOS PHARMA -- AGIO 27 Nov 2014 Ford Investor Services, Inc. 1 12.00
AGIOS PHARMACT (AGIO) Zacks Company Snapshot 26 Nov 2014 Zacks Investment Research Inc. 1 12.00
AGIOS PHARMACT (AGIO) Zacks Company Snapshot 25 Nov 2014 Zacks Investment Research Inc. 1 12.00
AGIOS PHARMACT (AGIO) Zacks Company Snapshot 24 Nov 2014 Zacks Investment Research Inc. 1 12.00
TheStreet.com Ratings Stock Report For: AGIOS PHARMACEUTICALS (AGIO) 22 Nov 2014 TheStreet.com Ratings 5 10.00
AGIO.OQ - Event Transcript of Agios Pharmaceuticals Inc conference call, Nov. 19, 2014 / 10:00AM ET 19 Nov 2014 Thomson Reuters StreetEvents 17 75.00
 
Name Age Since Current Position

David Schenkein

56 2013 Chief Executive Officer, Director

Duncan Higgons

59 Chief Operating Officer

Shin-San Michael Su

2012 Senior Vice President - research & development

Scott Biller

58 Chief Scientific Officer

Chris Bowden

2014 Chief Medical Officer
Search Stocks